The Briefing

Continuous newsroom coverage of clinically relevant evidence — newest first.

Earlier

24 stories
  1. CSF Tau Biomarkers Associate With Cognitive Impairment in ALS
    Annals of Neurology ·Cohort Study · May 13, 2026

    CSF Tau Biomarkers Associate With Cognitive Impairment in ALS

    Elevated cerebrospinal fluid tau levels correlate with cognitive deficits in ALS, though postmortem TDP-43 burden remains a stronger driver.

  2. Dihydroartemisinin-Piperaquine Reduces Early Plasmodium vivax Recurrence Compared With Chloroquine
    Lancet. Infectious diseases ·Randomized Controlled Trial · May 13, 2026

    Dihydroartemisinin-Piperaquine Reduces Early Plasmodium vivax Recurrence Compared With Chloroquine

    A randomized trial in Brazil shows dihydroartemisinin-piperaquine effectively prevents early malaria recurrence when primaquine is delayed.

  3. Validated 33-Item Instrument Quantifies Patient Misconceptions Regarding Hospice Care
    Journal of Pain and Symptom Management ·Cross-Sectional Study · May 13, 2026

    Validated 33-Item Instrument Quantifies Patient Misconceptions Regarding Hospice Care

    The Hospice Perceptions Instrument identifies specific barriers to enrollment, including myths about eligibility and service quality.

  4. Early Cystography After Bladder Repair Reduces Catheter Time and Infections
    Journal of Trauma: Injury, Infection, and Critical Care ·Cohort Study · May 13, 2026

    Early Cystography After Bladder Repair Reduces Catheter Time and Infections

    Imaging within seven days of traumatic bladder repair safely shortens catheterization and lowers infection rates without missing leaks.

  5. Dementia With Lewy Bodies Incidence Rises Sharply After Age 65
    JAMA Neurology ·Meta-Analysis · May 13, 2026

    Dementia With Lewy Bodies Incidence Rises Sharply After Age 65

    A meta-analysis of population-based studies reveals significant age and sex disparities in dementia with Lewy bodies epidemiology.

  6. Single Sigmoidoscopy Reduces Male Colorectal Cancer Death at 23 Years
    Annals of Internal Medicine ·Randomized Controlled Trial · May 13, 2026

    Single Sigmoidoscopy Reduces Male Colorectal Cancer Death at 23 Years

    A Norwegian trial shows a single screening sigmoidoscopy provides long-term protection for men, but mortality benefits are absent in women.

  7. Beti-cel Gene Therapy Sustains Transfusion Independence for Up to Ten Years
    Blood ·Cohort Study · May 13, 2026

    Beti-cel Gene Therapy Sustains Transfusion Independence for Up to Ten Years

    Long-term data show 90.2% of phase 3 patients achieved transfusion independence with stable hemoglobin and improved iron homeostasis.

  8. Palliative Care Reduces Hospital Death Risk in Multiple Sclerosis
    Neurology ·Cohort Study · May 13, 2026

    Palliative Care Reduces Hospital Death Risk in Multiple Sclerosis

    A large cohort study finds neurology oversight drops sharply before death, while rural patients face higher hospital mortality rates.

  9. Tenecteplase Before Thrombectomy Does Not Improve Late-Window Stroke Outcomes
    JAMA ·Randomized Controlled Trial · May 13, 2026

    Tenecteplase Before Thrombectomy Does Not Improve Late-Window Stroke Outcomes

    A phase 3 trial in patients with proximal MCA occlusions found no functional benefit to adding tenecteplase between 4.5 and 24 hours.

  10. Nuclear Membrane Disruption Precedes Cytoplasmic Tau in Anti-IgLON5 Disease
    Brain ·Mixed-Methods Study · May 13, 2026

    Nuclear Membrane Disruption Precedes Cytoplasmic Tau in Anti-IgLON5 Disease

    Autopsy and in vitro data show that antibody binding triggers nuclear invaginations and serine 422 phosphorylation before tau aggregates.

  11. Comorbidity Drives Genetic Overlap Between Anxiety and Major Depression
    Biological psychiatry ·Genome-Wide Association Study · May 12, 2026

    Comorbidity Drives Genetic Overlap Between Anxiety and Major Depression

    Excluding comorbid cases reveals that isolated anxiety and depression are more genetically distinct than previously recognized.

  12. Digoxin Reduces Heart Failure Risk in Rheumatic Heart Disease
    JAMA ·Randomized Controlled Trial · May 12, 2026

    Digoxin Reduces Heart Failure Risk in Rheumatic Heart Disease

    A randomized trial in India shows low-dose digoxin decreases the composite risk of death or worsening heart failure by 18 percent.

  13. Nurse-Led School CPR Program Multiplies Community Training Reach
    Annals of Emergency Medicine ·Cohort Study · May 12, 2026

    Nurse-Led School CPR Program Multiplies Community Training Reach

    Students using low-cost manikins trained an average of 2.4 family members, significantly expanding the pool of potential bystanders.

  14. POT1 Mutations Drive Lymphoid Malignancy Through Ultralong Telomeres
    Blood ·Cohort Study · May 12, 2026

    POT1 Mutations Drive Lymphoid Malignancy Through Ultralong Telomeres

    Pathogenic POT1 variants increase lymphoma risk eightfold by extending cellular longevity and promoting age-dependent clonal expansion.

  15. Transradial Access Does Not Increase Radiation in Aneurysm Treatment
    European Radiology ·Cohort Study · May 12, 2026

    Transradial Access Does Not Increase Radiation in Aneurysm Treatment

    A comparative study finds no significant difference in radiation dose between radial and femoral routes for endovascular repair.

  16. Subthalamic Signal Propagation Predicts Parkinsonian Motor State
    Brain ·Cohort Study · May 12, 2026

    Subthalamic Signal Propagation Predicts Parkinsonian Motor State

    Movement-related high-frequency oscillations propagate along the inferior-superior axis, correlating with levodopa response.

  17. Neurosurgeons Disagree on Resectability in Recurrent Glioblastoma Trial
    Neuro-Oncology ·Cohort Study · May 12, 2026

    Neurosurgeons Disagree on Resectability in Recurrent Glioblastoma Trial

    A post-hoc analysis reveals low inter-rater agreement on surgical feasibility and no link between surgeon consensus and survival.

  18. Small Vessel Disease Explains Reduced Thrombectomy Benefit in Older Patients
    Annals of Neurology ·Randomized Controlled Trial · May 12, 2026

    Small Vessel Disease Explains Reduced Thrombectomy Benefit in Older Patients

    A secondary analysis of the RESILIENT trial finds that CT markers of brain frailty, not age alone, predict poor functional outcomes.

  19. Low-Dose Digoxin Fails to Reduce Heart Failure Events in Randomized Trial
    Nature Medicine ·Randomized Controlled Trial · May 12, 2026

    Low-Dose Digoxin Fails to Reduce Heart Failure Events in Randomized Trial

    A study of 1,001 patients found targeting low serum concentrations did not significantly lower mortality or urgent hospital visits.

  20. Early Magnesium Sulfate Linked to Lower Mortality in Pneumonia
    Journal of Intensive Care Medicine ·Cohort Study · May 12, 2026

    Early Magnesium Sulfate Linked to Lower Mortality in Pneumonia

    A retrospective analysis of 9,203 ICU patients suggests early intravenous magnesium may reduce 30-day mortality risk by 16 percent.

  21. Resident Response Vehicles Increase Exposure to High-Acuity Prehospital Care
    Prehospital Emergency Care ·Cohort Study · May 12, 2026

    Resident Response Vehicles Increase Exposure to High-Acuity Prehospital Care

    A five-year study shows dedicated field vehicles provide residents with over 1,300 cardiac arrests and 2,000 medical control consults.

  22. ACL Reconstruction Triples 20-Year Risk of Knee Arthroplasty
    British Journal of Sports Medicine ·Cohort Study · May 12, 2026

    ACL Reconstruction Triples 20-Year Risk of Knee Arthroplasty

    A study of 135,881 patients shows a 2.44% absolute risk of knee replacement two decades after surgery, rising with meniscal involvement.

  23. Quality Improvement Shortens Time to Antibiotics in Pediatric Intestinal Failure
    Pediatric Emergency Care ·Cohort Study · May 12, 2026

    Quality Improvement Shortens Time to Antibiotics in Pediatric Intestinal Failure

    Multidisciplinary interventions reduced median cephalosporin delivery time by 58% for children with suspected central line infections.

  24. Glofitamab Shows High Response Rates in Refractory Aggressive B-Cell Lymphoma
    American Journal of Hematology ·Cohort Study · May 12, 2026

    Glofitamab Shows High Response Rates in Refractory Aggressive B-Cell Lymphoma

    Real-world data link baseline CD4+ effector T cells and early CD8+ expansion to improved outcomes with bispecific antibody therapy.